<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" bill-type="olc" dms-id="HF96B0DFEC6724ED6866061DFB3F31F8B" key="H" public-private="public"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>115 HR 3991 IH: Expanded Access to Opioid Abuse Treatment Act of 2017</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2017-10-06</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">115th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 3991</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20171006">October 6, 2017</action-date><action-desc><sponsor name-id="L000580">Ms. Michelle Lujan Grisham of New Mexico</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on <committee-name committee-id="HJU00">the Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such
			 provisions as fall within the jurisdiction of the committee concerned</action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend section 303(g)(2) of the Controlled Substances Act to allow certain pharmacists to
			 dispense narcotic drugs for maintenance or detoxification treatment
			 pursuant to the same waiver provisions as apply with respect to nurse
			 practitioners and physician assistants.</official-title></form>
	<legis-body id="HFAF511CD7FA34EBE97FB4D514FD56826" style="OLC">
 <section id="HFA08AC5BD6DA44E1A9F0199E732A9ABD" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Expanded Access to Opioid Abuse Treatment Act of 2017</short-title></quote>.</text> </section><section id="HEC943D94E9C94C4A887F2943FF15C47E"><enum>2.</enum><header>Eligibility of certain pharmacists for waivers for dispensing narcotic drugs for maintenance or detoxification treatment</header><text display-inline="no-display-inline">Section 303(g)(2)(G)(iv) of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/823">21 U.S.C. 823(g)(2)(G)(iv)</external-xref>) is amendedâ€”</text>
 <paragraph id="H3B5BECC579844D7D9890A32C21E3540B"><enum>(1)</enum><text>by striking <quote>nurse practitioner or physician assistant</quote> each place it appears and inserting <quote>nurse practitioner, physician assistant, or pharmacist</quote>; and</text> </paragraph><paragraph id="HAAB862BF696144F0BB6EF2611D417115"><enum>(2)</enum><text>in subclause (II)(aa), by inserting <quote>the American Pharmacists Association,</quote> before <quote>or any other organization</quote>.</text>
			</paragraph></section></legis-body></bill>


